Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Corbett

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 5, 1992
Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysisA H Corbett, R F DeVore, N Osheroff
Biochemistry|March 2, 1993
Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylationA H Corbett, A W Fernald, N Osheroff
Biochemistry|April 13, 1993
Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase IIM J Robinson, A H Corbett, N Osheroff
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Mechanism of action of topoisomerase II-targeted antineoplastic drugsN Osheroff, A H Corbett, M J Robinson
Molecular Biology of the Cell|August 10, 2000
The interaction between Ran and NTF2 is required for cell cycle progressionB B Quimby, C A Wilson, A H Corbett
Antimicrobial Agents and Chemotherapy|December 1, 1993
A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potentialA H Corbett, P Guerry, P Pflieger, et al.
The Journal of Biological Chemistry|October 20, 2000
Dissection of a nuclear localization signalM R Hodel, A H Corbett, A E Hodel
Molecular Genetics and Genomics : MGG|August 29, 2001
Functional analysis of the yeast Ran exchange factor Prp20p: in vivo evidence for the RanGTP gradient modelN Akhtar, H Hagan, J E Lopilato, et al.
Journal of Structural Biology|October 29, 2000
Crystallization and initial X-ray diffraction characterization of complexes of FxFG nucleoporin repeats with nuclear transport factorsR Bayliss, H M Kent, A H Corbett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classesN Osheroff, A H Corbett, S H Elsea, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 5, 1992
Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysisA H Corbett, R F DeVore, N Osheroff
Biochemistry|March 2, 1993
Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylationA H Corbett, A W Fernald, N Osheroff
Biochemistry|April 13, 1993
Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase IIM J Robinson, A H Corbett, N Osheroff
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
Mechanism of action of topoisomerase II-targeted antineoplastic drugsN Osheroff, A H Corbett, M J Robinson
Molecular Biology of the Cell|August 10, 2000
The interaction between Ran and NTF2 is required for cell cycle progressionB B Quimby, C A Wilson, A H Corbett
Antimicrobial Agents and Chemotherapy|December 1, 1993
A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potentialA H Corbett, P Guerry, P Pflieger, et al.
The Journal of Biological Chemistry|October 20, 2000
Dissection of a nuclear localization signalM R Hodel, A H Corbett, A E Hodel
Molecular Genetics and Genomics : MGG|August 29, 2001
Functional analysis of the yeast Ran exchange factor Prp20p: in vivo evidence for the RanGTP gradient modelN Akhtar, H Hagan, J E Lopilato, et al.
Journal of Structural Biology|October 29, 2000
Crystallization and initial X-ray diffraction characterization of complexes of FxFG nucleoporin repeats with nuclear transport factorsR Bayliss, H M Kent, A H Corbett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classesN Osheroff, A H Corbett, S H Elsea, et al.
Pageof 4